Mon, July 27, 2009
Fri, July 24, 2009
Thu, July 23, 2009
Wed, July 22, 2009
Tue, July 21, 2009
Mon, July 20, 2009
Fri, July 17, 2009
Thu, July 16, 2009
Wed, July 15, 2009
Tue, July 14, 2009
Mon, July 13, 2009
Fri, July 10, 2009
Thu, July 9, 2009
Wed, July 8, 2009
Tue, July 7, 2009
Mon, July 6, 2009
Fri, July 3, 2009
Thu, July 2, 2009
Wed, July 1, 2009
Tue, June 30, 2009
Mon, June 29, 2009
Sun, June 28, 2009
Fri, June 26, 2009
Thu, June 25, 2009
Wed, June 24, 2009
Tue, June 23, 2009
Mon, June 22, 2009
Fri, June 19, 2009
Thu, June 18, 2009
Wed, June 17, 2009
Tue, June 16, 2009
Mon, June 15, 2009
Sun, June 14, 2009
Fri, June 12, 2009
Thu, June 11, 2009
Wed, June 10, 2009
Tue, June 9, 2009
Mon, June 8, 2009
Sun, June 7, 2009
Fri, June 5, 2009
Thu, June 4, 2009
Wed, June 3, 2009
Tue, June 2, 2009
Mon, June 1, 2009
Fri, May 29, 2009
Thu, May 28, 2009
Wed, May 27, 2009
Tue, May 26, 2009
Mon, May 25, 2009
Fri, May 22, 2009
Thu, May 21, 2009
Wed, May 20, 2009
Tue, May 19, 2009
Mon, May 18, 2009
Sun, May 17, 2009
Fri, May 15, 2009
Thu, May 14, 2009
Wed, May 13, 2009
Tue, May 12, 2009
Mon, May 11, 2009
Fri, May 8, 2009
Thu, May 7, 2009
Fri, May 1, 2009
Thu, April 16, 2009
Wed, April 15, 2009

Paladin Labs Inc. Paladin Labs Inc. Signs Exclusive Agreement With Sylphar N. V.

  Copy link into your clipboard //house-home.news-articles.net/content/2009/06/1 .. -signs-exclusive-agreement-with-sylphar-n-v.html
  Print publication without navigation Published in House and Home on , Last Modified on 2009-06-18 05:25:23 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

MONTREAL, CANADA and DEURLE, BELGIUM--(Marketwire - June 18, 2009) - Paladin Labs Inc., (TSX:PLB), a leading Canadian specialty pharmaceutical company, and Sylphar N.V., today announced that they have entered into an agreement to develop and market an oral dissolving teeth whitening film strip in Europe. Under this agreement, Sylphar and Paladin plan to sell their first product in June 2009. Paladin will assume responsibility for the development, manufacturing and packaging of the product. This partnership agreement gives Paladin the opportunity to lead the way in bringing an oral dissolving teeth whitening film strip technology to Europe.

Robin List, CEO of Sylphar NV said: "We are very happy to commercialize, under our brand name WhizzerTM, the innovative whitening system exploiting Paladin's high professional nutraceutical & pharmaceutical knowledge. WhizzerTM represents an important opportunity in order to cover a very fast growing consumer need with a unique easy-to-use home whitening program. We strongly believe WhizzerTM has the potential to become in the next months one of most representative brands inside Sylphar's portfolio."

"We are thrilled to partner with the world leader in marketing of oral care and OTC products," said Jonathan Ross Goodman, President and CEO of Paladin Labs.

"We are also pleased that Sylphar recognizes BioEnvelop® as being a valuable partner in the advancement of a new technology in Europe," said Etan Jagermann, COO of BioEnvelop®.

About the oral dissolving teeth whitening film strip

- 56 rapid dissolving strips (one month supply)

- Invisible, thin peroxide strips that stick to your teeth

- Dissolves after 5-10 minutes

- Once a day

- 6% H2O2

- Convenient / Comfortable: use anywhere at anytime

- Triple dental care: whitens, refreshes, kills oral bacteria

- Maintains oral health

- Enamel-safe

- Nothing to remove, no mess

- Easy: open, apply, dissolves

About Sylphar

Sylphar, a privately held company with offices in Belgium, Singapore and the United States, strives to be a world leader in marketing of oral care and otc products. Sylphar's products are renowned for their technological superiority and ease-of-use. Based in Deurle, Belgium, Sylphar has successfully researched all of its own products. These products are now distributed in more than 35 countries worldwide and are exclusively sold through pharmacies and drugstores. For further information about Sylphar please visit the Company's web site at [ www.sylphar.com ].

About BioEnvelop®

Founded in 1998, BioEnvelop® designs and manufactures state-of-the-art Delivery Systems of Active Ingredients in both film and gel formats that have wide applications in the Medical & Dental, Health & Wellness and Oral Care industries. BioEnvelop® has a license to manufacture under the Natural Health Products (NHP) certification program of Canada. BioEnvelop® continues to offer many new opportunities for nutraceutical companies to change from a current product format into a new delivery system or just begin with an entirely new product application. In either case, BioEnvelop® has the passion, the resources and the complete focus to execute the introduction of a new product delivery concept to the marketplace and is constantly looking for new technologies and partnerships. For further information about BioEnvelop® please visit the Company's web site at [ www.bioenvelop.com ].

About Paladin Labs Inc

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Company's web site at [ www.paladinlabs.com ].

This press release may contain forward-looking statements and predictions. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiary, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report as well as in the Company's Annual Information Form for the year ended December 31, 2008. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information or future events and except as required by law. For additional information on risks and uncertainties relating to these forward-looking statements, investors should consult the Company's ongoing quarterly fillings, annual report and Annual Information Form and other fillings found on SEDAR at [ www.sedar.com ]




Similar House and Home Publications